Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and hydration. Sodium chloride and potassium chloride replace extracellular fluid and electrolytes.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; rate and volume determined by patient's fluid, electrolyte, and caloric requirements; typical adult dose is 1000-2000 mL per 24 hours, infused at a rate of 50-100 mL/hour.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Not applicable as a primary pharmacokinetic parameter for this combination; dextrose follows glucose disposition with a half-life of approximately 1-2 hours in euglycemic individuals, prolonged in diabetes. Electrolytes distribute and are eliminated with functional half-lives reflecting renal handling (e.g., potassium half-life ~6-8 hours).
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is metabolized to carbon dioxide and water, with negligible renal elimination of unchanged glucose unless hyperglycemia exceeds renal threshold. Sodium and chloride are primarily excreted renally, with >90% of filtered sodium reabsorbed; potassium is predominantly excreted renally (90%) with minor fecal loss (<10%) under normal renal function.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte